Peerapat Thanapongsatorn และผู้แต่งคนอื่นๆ. (2022) Spironolactone to Prevent the Progression of Vascular Calcification among Peritoneal Dialysis Patients: A Pilot Randomised Controlled Trial (SV-CAPD trial). <i>Vajira Medical Journal</i>, <i>66</i>(6), 415-426.Peerapat Thanapongsatorn และผู้แต่งคนอื่นๆ. "Spironolactone to Prevent the Progression of Vascular Calcification among Peritoneal Dialysis Patients: A Pilot Randomised Controlled Trial (SV-CAPD trial)". Vajira Medical Journal 66 (2022):415-426.Peerapat Thanapongsatorn และผู้แต่งคนอื่นๆ. Spironolactone to Prevent the Progression of Vascular Calcification among Peritoneal Dialysis Patients: A Pilot Randomised Controlled Trial (SV-CAPD trial). Text and Journal Publication:ม.ป.ท. 2022.